BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7868223)

  • 1. Isolation of Pasteurella haemolytica leukotoxin mutants.
    Chidambaram M; Sharma B; Petras SF; Reese CP; Froshauer S; Weinstock GM
    Infect Immun; 1995 Mar; 63(3):1027-32. PubMed ID: 7868223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and virulence properties of Pasteurella haemolytica leukotoxin mutants.
    Petras SF; Chidambaram M; Illyes EF; Froshauer S; Weinstock GM; Reese CP
    Infect Immun; 1995 Mar; 63(3):1033-9. PubMed ID: 7868224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the leukotoxin determinants from Pasteurella haemolytica serotypes 1 to 16.
    Burrows LL; Olah-Winfield E; Lo RY
    Infect Immun; 1993 Dec; 61(12):5001-7. PubMed ID: 8225575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mosaic structure and molecular evolution of the leukotoxin operon (lktCABD) in Mannheimia (Pasteurella) haemolytica, Mannheimia glucosida, and Pasteurella trehalosi.
    Davies RL; Campbell S; Whittam TS
    J Bacteriol; 2002 Jan; 184(1):266-77. PubMed ID: 11741868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Hemolysis May Not Be a Reliable Indicator of Leukotoxicity of
    Bavananthasivam J; Shanthalingam S; Kugadas A; Raghavan B; Batra S; Srikumaran S
    Toxins (Basel); 2018 Apr; 10(5):. PubMed ID: 29693562
    [No Abstract]   [Full Text] [Related]  

  • 6. Generation of targeted nonpolar gene insertions and operon fusions in Pasteurella haemolytica and creation of a strain that produces and secretes inactive leukotoxin.
    Fedorova ND; Highlander SK
    Infect Immun; 1997 Jul; 65(7):2593-8. PubMed ID: 9199425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of an isogenic leukotoxin deletion mutant of Pasteurella haemolytica serotype 1: characterization and virulence.
    Tatum FM; Briggs RE; Sreevatsan SS; Zehr ES; Ling Hsuan S; Whiteley LO; Ames TR; Maheswaran SK
    Microb Pathog; 1998 Jan; 24(1):37-46. PubMed ID: 9466945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological effects of two genetically defined leukotoxin mutants of Mannheimia haemolytica.
    Thumbikat P; Briggs RE; Kannan MS; Maheswaran SK
    Microb Pathog; 2003 May; 34(5):217-26. PubMed ID: 12732470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pasteurella haemolytica leukotoxin induces bovine leukocytes to undergo morphologic changes consistent with apoptosis in vitro.
    Stevens PK; Czuprynski CJ
    Infect Immun; 1996 Jul; 64(7):2687-94. PubMed ID: 8698496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the Pasteurella haemolytica leukotoxin is inhibited by a locus that encodes an ATP-binding cassette homolog.
    Highlander SK; Wickersham EA; Garza O; Weinstock GM
    Infect Immun; 1993 Sep; 61(9):3942-51. PubMed ID: 8359916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of Pasteurella (Mannheimia) haemolytica leukotoxin causes partial attenuation of virulence in a calf challenge model.
    Highlander SK; Fedorova ND; Dusek DM; Panciera R; Alvarez LE; Rinehart C
    Infect Immun; 2000 Jul; 68(7):3916-22. PubMed ID: 10858203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Static DNA bending and protein interactions within the Pasteurella haemolytica leukotoxin promoter region: development of an activation model for leukotoxin transcriptional control.
    Highlander SK; Weinstock GM
    DNA Cell Biol; 1994 Feb; 13(2):171-81. PubMed ID: 8179822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial characterization of the leukotoxin of Pasteurella haemolytica-like bacteria isolated from swine enteritis.
    DeSilva RT; Chengappa MM; Oberst RD; Staats JJ
    Vet Microbiol; 1995 Aug; 45(4):319-29. PubMed ID: 7483245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic activity of the Pasteurella haemolytica leukotoxin.
    Murphy GL; Whitworth LC; Clinkenbeard KD; Clinkenbeard PA
    Infect Immun; 1995 Aug; 63(8):3209-12. PubMed ID: 7622250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activity of Mannheimia haemolytica strains in relation to diversity of the leukotoxin structural gene lktA.
    Davies RL; Baillie S
    Vet Microbiol; 2003 Apr; 92(3):263-79. PubMed ID: 12523988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, nucleotide sequence, and characterization of genes encoding the secretion function of the Pasteurella haemolytica leukotoxin determinant.
    Strathdee CA; Lo RY
    J Bacteriol; 1989 Feb; 171(2):916-28. PubMed ID: 2914876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chimeric protein comprising the immunogenic domains of Mannheimia haemolytica leukotoxin and outer membrane protein PlpE induces antibodies against leukotoxin and PlpE.
    Batra SA; Shanthalingam S; Donofrio G; Srikumaran S
    Vet Immunol Immunopathol; 2016 Jul; 175():36-41. PubMed ID: 27269790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion and expression of the Pasteurella haemolytica Leukotoxin.
    Highlander SK; Engler MJ; Weinstock GM
    J Bacteriol; 1990 May; 172(5):2343-50. PubMed ID: 2185213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-condition dependent expression of Pasteurella haemolytica A1 outer membrane proteins, capsule, and leukotoxin.
    Gatewood DM; Fenwick BW; Chengappa MM
    Vet Microbiol; 1994 Aug; 41(3):221-33. PubMed ID: 7975148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of operon fusions in Mannheimia haemolytica to identify environmental and cis-acting regulators of leukotoxin transcription.
    Marciel AM; Highlander SK
    Infect Immun; 2001 Oct; 69(10):6231-9. PubMed ID: 11553565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.